Chengdu Olymvax Biopharmaceuticals Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Shaowen Fan
Chief executive officer
CN¥713.5k
Total compensation
CEO salary percentage | n/a |
CEO tenure | 14.9yrs |
CEO ownership | 3.9% |
Management average tenure | no data |
Board average tenure | 8.5yrs |
Recent management updates
Recent updates
Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected
Oct 09We Think Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Has A Fair Chunk Of Debt
Sep 30What Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 26% Share Price Gain Is Not Telling You
Jun 24Is There An Opportunity With Chengdu Olymvax Biopharmaceuticals Inc.'s (SHSE:688319) 27% Undervaluation?
May 28Chengdu Olymvax Biopharmaceuticals Inc. (SHSE:688319) Shares May Have Slumped 25% But Getting In Cheap Is Still Unlikely
Apr 18These 4 Measures Indicate That Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Is Using Debt Extensively
Mar 26CEO
Shaowen Fan (71 yo)
14.9yrs
Tenure
CN¥713,500
Compensation
Mr. Shaowen Fan is Chairman of the Board & GM of Chengdu Olymvax Biopharmaceuticals Inc. from January 2010. Mr. Fan joined the Chengdu Olymvax Biopharmaceuticals Inc. in 2010.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board & GM | 14.9yrs | CN¥713.50k | 3.86% CN¥ 185.9m | |
Director | 11.5yrs | CN¥42.00k | 0.014% CN¥ 664.4k | |
Chairman of Supervisory Board | 8.5yrs | no data | 6.38% CN¥ 307.1m | |
Executive Deputy GM & Vice Chairman of the Board | 14.9yrs | CN¥633.20k | 7.53% CN¥ 362.6m | |
Director | 2.6yrs | CN¥42.00k | 1.64% CN¥ 79.1m | |
Director | 14.9yrs | CN¥602.00k | 0.15% CN¥ 7.3m | |
Employee Representative Director | 2.6yrs | CN¥195.00k | 0.067% CN¥ 3.2m | |
Independent Director | 5.7yrs | CN¥83.90k | no data | |
Supervisor | 2.6yrs | no data | 0.20% CN¥ 9.7m |
8.5yrs
Average Tenure
61yo
Average Age
Experienced Board: 688319's board of directors are considered experienced (8.5 years average tenure).